title: Levosimendan improves cardiopulmonary resuscitation and survival by K(ATP) channel activation.
authors.forename: Gianluca A A M
authors.initials: GA
authors.lastname: Cammarata
authors.forename: Max Harry
authors.initials: MH
authors.lastname: Weil
authors.forename: Shijie
authors.initials: S
authors.lastname: Sun
authors.forename: Lei
authors.initials: L
authors.lastname: Huang
authors.forename: Xiangshao
authors.initials: X
authors.lastname: Fang
authors.forename: Wanchun
authors.initials: W
authors.lastname: Tang
mesh_terms: D000255:Adenosine Triphosphate; D000818:Animals; D016887:Cardiopulmonary Resuscitation; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D015221:Potassium Channels / Q000187:drug effects*; D011724:Pyridazines / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077464:Simendan; D015996:Survival Rate
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D015221:Potassium Channels; D011724:Pyridazines; D000077464:Simendan; D000255:Adenosine Triphosphate